Skip to main content
Log in

Zelrix and Levadex would be drugs of choice if priced better

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zelrix and Levadex would be drugs of choice if priced better. Pharmacoecon. Outcomes News 638, 11 (2011). https://doi.org/10.2165/00151234-201106380-00033

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-201106380-00033

Keywords

Navigation